Anika Therapeutics, Inc.
ANIK- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000898437
In the last 90 days, Anika Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 133 institutions reported holding it in 13F filings for Q2 2026, worth $179.0M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Anika Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 117
- +13 vs. Q2 2025
- Shares held
- 12.2M
- −453.4K (−3.6%) vs. Q2 2025
- Total value
- $115.0M
- −$19.2M (−14.3%) vs. Q2 2025
- New holders
- 25
- 47 more added
- Sold out
- 12
- 26 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 133 | $179.0M |
| Q1 2026 | 130 | $179.1M |
| Q4 2025 | 126 | $117.5M |
| Q3 2025 | 117 | $115.0M |
| Q2 2025 | 104 | $134.2M |
| Q1 2025 | 108 | $190.7M |
| Q4 2024 | 109 | $206.2M |
| Q3 2024 | 122 | $323.5M |
| Q2 2024 | 114 | $335.3M |
| Q1 2024 | 120 | $340.4M |
| Q4 2023 | 117 | $300.2M |
| Q3 2023 | 117 | $242.3M |
| Q2 2023 | 117 | $340.4M |
| Q1 2023 | 121 | $375.6M |
| Q4 2022 | 125 | $388.0M |
| Q3 2022 | 123 | $320.5M |
| Q2 2022 | 126 | $302.2M |
| Q1 2022 | 119 | $341.4M |
| Q4 2021 | 127 | $483.3M |
| Q3 2021 | 131 | $559.5M |
| Q2 2021 | 139 | $568.9M |
| Q1 2021 | 146 | $543.0M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Anika Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farther Finance Advisors, LLC | 121 | $1.14K | 0.00% | −1,655−93.2% | Reduced |
| Smartleaf Asset Management LLC | 111 | $1.01K | 0.00% | +67+152.3% | Added |
| Advisor Group Holdings, Inc. | 110 | $1.01K | 0.00% | 00.0% | Unchanged |
| Mather Group, LLC. | 100 | $940 | 0.00% | +100 | New |
| Massmutual Trust Co FSB | 91 | $855 | 0.00% | +55+152.8% | Added |
| Comerica Bank | 70 | $658 | 0.00% | +70 | New |
| True Wealth Design, LLC | 51 | $480 | 0.00% | +42+466.7% | Added |
| EverSource Wealth Advisors, LLC | 48 | $451 | 0.00% | −64−57.1% | Reduced |
| Nisa Investment Advisors, LLC | 41 | $385 | 0.00% | −1,213−96.7% | Reduced |
| Clearstead Advisors, LLC | 32 | $301 | 0.00% | −12−27.3% | Reduced |
| IFP Advisors, Inc | 23 | $216 | 0.00% | +23 | Added |
| Advisory Services Network, LLC | 12 | $113 | 0.00% | +12 | New |
| Allworth Financial LP | 11 | $104 | 0.00% | −1−8.3% | Reduced |
| SBI Securities Co., Ltd. | 8 | $75 | 0.00% | +2+33.3% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 1 | $9 | 0.00% | +1 | New |
| Covestor Ltd | 35 | $0 | 0.00% | +18+105.9% | Added |
| Simplex Trading, LLC | 104 | $0 | 0.00% | +104 | New |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −588,797−100.0% | Sold out |
| Alta Fundamental Advisers LLC | 0 | $0 | 0.00% | −454,944−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −190,590−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −64,872−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −15,735−100.0% | Sold out |
| Gallagher Fiduciary Advisors, LLC | 0 | $0 | 0.00% | −13,347−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −13,096−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,568−100.0% | Sold out |
| Shell Asset Management Co | 0 | $0 | 0.00% | −1,332−100.0% | Sold out |
| Glenmede Investment Management, LP | 0 | $0 | 0.00% | −1,220−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |